type here...

Analysis

Analysis

European Cannabis Stocks Review: SEED Loses Recent Gains As Stock Drops 30%, DanCann Performs Well Despite Lower Estimates, & More From DeepVerge

THIS week saw news emerge that countries across the globe were making significant moves towards the liberalisation of cannabis regulation, with Spain, Japan and...
Ben Stevens -
Analysis

European Cannabis Stocks Review: SEED Innovations Shares Spike 25%, Futura Medical Signs Commercialisation Deal, & More From Akanda

AS quarterly and full-year results continued to be published across the global cannabis industry, European stocks enjoyed a relatively stable week compared to their...
Ben Stevens -
Analysis

European Cannabis Stocks Roundup: Aurora Stocks Jump On EU Medical Market Growth Despite $1bn Loss

IT'S been a jam-packed week for the global cannabis industry as a host of companies including Aurora, Halo Collective, Dancann Pharma, Yooma Wellness and...
Ben Stevens -
Analysis

European Cannabis Stocks Review: Akanda Dives Over 80% & Celadon Suffers After Reporting Huge Rise In Losses

This week was another difficult week for London Stock Exchange (LSE) listed cannabis companies, with every one of BusinessCann's tracked stocks reporting declines, including...
Ben Stevens -
Analysis

EU Cannabis Stocks Review: Love Hemp & Yooma Wellness Both See Their Shares Suspended

It has been another dramatic week on the global markets, with the Pound Sterling falling to a 2022-low and the NASDAQ registering its biggest...
Ben Stevens -
Analysis

EU Cannabis Stocks Review: Akanda’s Streak Comes To Abrupt End & Chill Brands New CEO Has His Work Cut Out To Recover Losses

This week was another difficult week for cannabis stocks across global markets, with a number of external factors seeing both the NASDAQ and LSE...
Ben Stevens -
Analysis

European Cannabis Stocks Review: FSA Makes ‘Final Call’ For Evidence As Cellular Goods’ Stock Recovers From Confusion Over Its Products’ Inclusion

THE fallout from the publication of the FSA's Public List is continuing to be felt on the stock markets this week, with the regulator...
Ben Stevens -
Analysis

What Is The Canpain Study And Will It Help Bring CBMPs Onto The NHS?

THE UK’s Health Research Authority (HRA) has approved the country’s first clinical study using cannabis flower for the treatment of chronic pain.  While the study,...
Ben Stevens -
Analysis

EU Cannabis Stocks Review: SEED Innovations Eurox Investment Bears Fruit, Akanda Continues To Climb & Intercure Posts Record Figures

Despite a number of positive announcements coming from the UK this week, British cannabis stocks failed to match the dramatic upswings experienced by their...
Ben Stevens -
Analysis

Over 340,000 Patients In Europe Set To Benefit From Medical Cannabis Access In 2022

NEW sales forecasts for the medical cannabis market in Europe predict that €353 million-worth of medical cannabis will be sold on the continent in...
Ben Stevens -
Analysis

EU Cannabis Stocks Review: Board Changes At Kanabo & Cellular Goods, Panaxia Stages Comeback & Akanda Continues Rally

European cannabis stocks had another generally positive week last week, with some major announcements from the North American market prop-up gains across the continent.  Mid-week...
Ben Stevens -
Analysis

EU Cannabis Stocks Review: Cellular Goods Stock Jumps 50% After Marketing Campaign Launch, SEED Innovations Enjoys Recovery, More from DeepVerge & Akanda

FOLLOWING a difficult few weeks for European cannabis stocks, last week saw many enjoy a recovery amid a flurry of positive announcements from both...
Ben Stevens -
Analysis

EU Cannabis Stocks Review: OCT Board Accused of Serious Governance Issues by Co-Founder, Panaxia’s Debt Pile Hits Stock & More from Love Hemp

AS European Cannabis stocks continue their battle against external market forces, it has been internal battles which made the headlines this week.  Major stakeholders of...
Ben Stevens -
Analysis

One Year After The First Cannabis Stocks Joined The LSE, Could We See A Fresh Run Of Cannabis IPOs This Year?

FEBRUARY 2022 marked the one-year anniversary of MGC Pharmaceuticals IPO on the London Stock Exchange, which saw cannabis stocks traded on the platform for the first time in its 320-year history. 
Ben Stevens -
Analysis

EU Cannabis Stocks Review: How Ukraine Crisis Is Impacting Cannabis Stocks, Chill Brands’ Revenue Could Be $1m Less & More From Tilray and MGC...

LAST week began with a number of European cannabis stocks levelling out following dramatic declines days earlier in reaction to Russia’s invasion of Ukraine.  While...
Ben Stevens -
Analysis

EU Cannabis Stocks Review: Stenocare Enters UK, Cellular Goods’ Sales Disappoint & Ukraine Crisis Hammers Stocks

The tragic developments in Ukraine hit global markets hard last week, and cannabis stocks even harder. As Europe’s worst fears were realised on Thursday...
Ben Stevens -
Analysis

EU Cannabis Stocks Review: OCT’s Co-Founder Demands Removal Of All 6 Directors – More from Akanda, MGC Pharmaceuticals & Apollon

We start this week's EU Cannabis Stocks Review with some breaking news from Oxford Cannabinoid Technologies, after the company's co-founder calls for a general meeting in an attempt enact a dramatic management overhaul.
Ben Stevens -
1234Page 3 of 4

Latest news

Comment

A ‘Momentous Occasion’ For Hemp With Its Multiple Attributes Recognised At The United Nations

After 60-plus years of negativity and prohibition the tide has turned for hemp at the highest levels of global...
Press Releases

Transparency For Cannabis Pilot Trials In Switzerland

PRESS RELEASE FOR the first time, cannabis is being sold legally in Switzerland. On 30 January, selected participants of the...
News

New ‘Semi-Synthetic’ THC Alternative HHC Could Encourage Regulatory Crack Down On Hemp Flower

AT the end of 2022 the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) held its first ‘technical...

Must read

Comment

A ‘Momentous Occasion’ For Hemp With Its Multiple Attributes Recognised At The United Nations

After 60-plus years of negativity and prohibition the tide...
News

New ‘Semi-Synthetic’ THC Alternative HHC Could Encourage Regulatory Crack Down On Hemp Flower

AT the end of 2022 the European Monitoring Centre...

You might also likeRELATED
Recommended to you

Medicinal Cannabis

Fall in Number Of UK Cannabis Users

ONE of the UK’s leading cannabis experts says the...
Peter -
Medicinal Cannabis

Fall in Number Of UK Cannabis Users

ONE of the UK’s leading cannabis experts says the...
Peter -
Medicinal Cannabis

Fall in Number Of UK Cannabis Users

ONE of the UK’s leading cannabis experts says the...
Peter -

Editor Picks

Must Read

BusinessCann

About BusinessCann

BusinessCann delivers news, features, comment and analysis with the people and businesses forging Europe’s hemp, medicinal cannabis and CBD wellness sectors.

Advertise | Contact Us | Terms & Conditions | Privacy Policy | Disclaimer

Follow Us

© 2023 - BusinessCann.com. All Rights Reserved.